Pioglitazone Ameliorates Lipopolysaccharide-Induced Behavioral Impairment, Brain Inflammation, White Matter Injury and Mitochondrial Dysfunction in Neonatal Rats

Previous studies have demonstrated that pioglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, inhibits ischemia-induced brain injury. The present study was conducted to examine whether pioglitazone can reduce impairment of behavioral deficits mediated by inflammatory-indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Jiann-Horng, Wang, Kuo-Ching, Kaizaki, Asuka, Lee, Jonathan W., Wei, Han-Chi, Tucci, Michelle A., Ojeda, Norma B., Fan, Lir-Wan, Tien, Lu-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231261/
https://www.ncbi.nlm.nih.gov/pubmed/34208374
http://dx.doi.org/10.3390/ijms22126306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231261/
https://www.ncbi.nlm.nih.gov/pubmed/34208374
http://dx.doi.org/10.3390/ijms22126306

Ejemplares similares